SOL Global Investments Corp. engages in the research and development of drug therapies. It specializes in the development of a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. The company was founded by Jonathan Gilbert on January 28, 2005 and is headquartered in Toronto, Canada.